Follow Us
© 2026 Arizent. All rights reserved.
Whether you're shaping benefits, guiding clinical strategy, or advising employers, this session will give you the data and the framework to put cancer back on the executive radar.
Leave of absence is more than an HR process—it can have a significant impact on employee wellbeing, productivity, retention, and the bottom line. When organizations take a reactive approach, burnout, caregiving challenges, and mental health concerns can escalate into costly leaves and even employee turnover.
Healthcare costs are squeezing employer margins, and small and midsize employers aren't waiting for another renewal to act. They're rethinking how they fund healthcare, manage costs, and partner with advisors.
Explore what's possible when AI makes benefits personal, proactive, and easy to use.
“Sed ut perspiciatis unde omnis iste natus error sit voluptatem accusantium doloremque laudantium, totam rem aperiam, eaque ipsa quae ab illo inventore veritatis et quasi architecto beatae vitae dicta sunt explicabo. Nemo enim ipsam voluptatem quia voluptas sit aspernatur aut odit aut fugit, sed quia consequuntur magni dolores eos qui ratione voluptatem sequi nesciunt. Neque […]
Clean pricing, broken results. Stop trusting the RFP and start evaluating what actually delivers for your clients.
GLP-1 coverage decisions were the easy part. Two years in, employers are facing the harder question: what happens when people stop the medication. Discontinuation is common, weight often returns, and the spend starts over. For benefits leaders heading into 2027 renewals, the risk is no longer access; it is durability.
More employers are asking about ICHRA. Learn how to lead the conversation before someone else does.
A practical guide and vendor questions for public sector benefits leaders evaluating onsite and near-site clinics.
Why medical trend hit 9% when members aren't getting sicker, and what benefits advisors can tell clients.
